Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Delayed Data
As of Nov 27
 +0.22 / +2.41%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 16.00 and a low estimate of 14.00. The median estimate represents a +60.43% increase from the last price of 9.35.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Merrimack Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 62.50%
Growthannually -34.38%


Growthquarterly 17.30%
Growthannually -16.70%
Key to the earnings and sales forecast charts.